United States · FDA National Drug Code directory
RenThyroid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64950-180_dd8b277c-6ec2-4e0b-9aec-c64089e18cfe
- Product NDC
- 64950-180
- Form
- TABLET
- Composition / generic term
- LEVOTHYROXINE and LIOTHYRONINE
- Labeler
- Genus Lifesciences
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20250301
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE — 47.5 ug/1
- LIOTHYRONINE — 11.25 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (64950-180-01) · 64950-180-01
- 90 TABLET in 1 BOTTLE (64950-180-09) · 64950-180-09
- 14 TABLET in 1 BOTTLE (64950-180-14) · 64950-180-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →